Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN953202 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Lysyl Oxidase-Like 2 (LOXL2) (AA 588-617), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Protein A column, followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- C-Term, AA 588-617
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Functional analysis of LOXL2 in pancreatic carcinoma.
Modulation of lysyl oxidase-like 2 enzymatic activity by an allosteric antibody inhibitor.
Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis.
The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1.
Rückert F, Joensson P, Saeger HD, Grützmann R, Pilarsky C
International journal of colorectal disease 2010 Mar;25(3):303-11
International journal of colorectal disease 2010 Mar;25(3):303-11
Modulation of lysyl oxidase-like 2 enzymatic activity by an allosteric antibody inhibitor.
Rodriguez HM, Vaysberg M, Mikels A, McCauley S, Velayo AC, Garcia C, Smith V
The Journal of biological chemistry 2010 Jul 2;285(27):20964-74
The Journal of biological chemistry 2010 Jul 2;285(27):20964-74
Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis.
Sano M, Aoyagi K, Takahashi H, Kawamura T, Mabuchi T, Igaki H, Tachimori Y, Kato H, Ochiai A, Honda H, Nimura Y, Nagino M, Yoshida T, Sasaki H
International journal of oncology 2010 Feb;36(2):321-30
International journal of oncology 2010 Feb;36(2):321-30
The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1.
Schietke R, Warnecke C, Wacker I, Schödel J, Mole DR, Campean V, Amann K, Goppelt-Struebe M, Behrens J, Eckardt KU, Wiesener MS
The Journal of biological chemistry 2010 Feb 26;285(9):6658-69
The Journal of biological chemistry 2010 Feb 26;285(9):6658-69
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
